Category: us corporate news

us corporate news

Silexion Therapeutics Receives Israeli Ministry of Health Approval for Phase 2/3 Clinical Trial of SIL204 in Advanced Pancreatic Cancer

Minichart

March 24, 2026

Silexion Therapeutics Receives Israeli Ministry of Health Ap...

Continue Reading 0

us corporate news

Vertiv to Acquire ThermoKey, Expanding Advanced Cooling Solutions for AI Data Centers in EMEA 1

Minichart

March 24, 2026

Vertiv to Acquire ThermoKey: Investor-Focused Analysis ...

Continue Reading 0

us corporate news

BioAge Labs Reports Positive 2025 Financial Results and Advances BGE-102 NLRP3 Inhibitor Toward Phase 2 Trials in Cardiovascular and Ophthalmology Indications

Minichart

March 24, 2026

BioAge Labs Reports Full Year 2025 Financial Results and Maj...

Continue Reading 0

us corporate news

Actelis Networks to Acquire Exaware, Entering AI Data Center Networking Market with All-Stock Deal 1

Minichart

March 24, 2026

Actelis Networks Announces Binding Term Sheet to Acquire Exa...

Continue Reading 0

us corporate news

ASP Isotopes and Quantum Leap Energy Partner with University of Bristol to Design UK Lithium Laser Enrichment Research Facility

Minichart

March 24, 2026

ASP Isotopes Announces Strategic Collaboration for Advanced ...

Continue Reading 0

us corporate news

Polaryx Therapeutics: Advancing Innovative Therapies for Rare Pediatric Lysosomal Storage Disorders (LSDs)

Minichart

March 24, 2026

Polaryx Therapeutics, Inc. 2025 Annual Report: Key Highlight...

Continue Reading 0

us corporate news

Ocean Thermal Energy Corp: OTEC and SWAC/LSC Renewable Energy Solutions, Market Strategy, and Risk Factors 2025

Minichart

March 24, 2026

Ocean Thermal Energy Corporation (CPWR) 2025 Annual Report –...

Continue Reading 0

us corporate news

Achieve Life Sciences, Inc. 2025 10-K Annual Report: Business Overview, Risk Factors, and Financial Highlights

Minichart

March 24, 2026

Achieve Life Sciences, Inc. 2025 Annual Report: Key Insights...

Continue Reading 0

us corporate news

COMPASS Pathways: COMP360 Psilocybin Treatment for Mental Health – Clinical Trials, Strategy, Risks, Patents, and Commercialization 3144535455

Minichart

March 24, 2026

Compass Pathways 2025 Annual Report: Key Highlights and Inve...

Continue Reading 0

us corporate news

Core & Main, Inc. 2026 Annual Report: Business Overview, Growth Strategies, Risks, and Financial Highlights

Minichart

March 24, 2026

Core & Main, Inc. 2026 Annual Report: Key Investor Takeaways...

Continue Reading 0